Zevra Therapeutics Inc (ZVRA)

EBITDA Margin

53.69%

TTM · Period ending:

ZVRA logo

ZVRA EBITDA Margin

Latest reported53.69%
ZVRA TTM EBITDA Margin (-160.53% → 53.69%)
High-resolution chart · PNG

ZVRA ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Zevra Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
53.6933%
114.8664%
92.7106%
79.6405%
58.7633%
-148.5759%
-323.5643%
-296.4738%
-240.2568%
-156.4502%
-153.0406%
-223.0605%
-179.9097%
-542.5897%
-393.9759%
-327.0684%
-312.128%
1.005%
-27.5009%
-29.7426%
-28.1891%
-49.7427%
-40.2092%
-50.992%
-7.9044%
-80.9084%
-149.0537%
-160.5252%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.